Dispute settlement understanding on the use of BOTOX ® in chronic migraine

Journal of Headache and Pain

Volumn 12, Issue 1, 2011, Pages 1-2

  Martelletti, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

DRUG INDUCED HEADACHE; EDITORIAL; HUMAN; PRIORITY JOURNAL; TRANSFORMED MIGRAINE;

BOTULINUM TOXINS, TYPE A; DRUG APPROVAL; HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; NEUROMUSCULAR AGENTS;

EID: 78651382988     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-010-0288-y     Document Type: Editorial

References (20)

1. J Olesen P Tfelt-Hansen 2010 Licence for Botox in so-called chronic migraine Lancet 376 1825 1826 21111904 10.1016/S0140-6736(10)62165-4
2. J Kyne 2010 Response from MHRA Lancet 376 1826 10.1016/S0140-6736(10) 62166-6
3. A Negro L D'Alonzo P Martelletti 2010 Chronic migraine: comorbidities, risk factors, and rehabilitation Intern Emerg Med 5 1 S13 S19 20865469 10.1007/s11739-010-0457-7
4. K Hagen R Jensen MG Bøe LJ Stovner 2010 Medication overuse headache: a critical review of end points in recent follow-up studies J Headache Pain 11 373 377 20473701 10.1007/s10194-010-0221-4
5. M Allena K Katsarava G Nappi The COMOESTAS Consortium 2009 From-drug-induced headache to medication overuse headache. A short-epidemiological review, with a focus on Latin American countries J Headache Pain 10 71 76 19238511 10.1007/s10194-009-0101-y
6. P Rossi R Jensen G Nappi M Allena The COMOESTAS Consortium 2009 A narrative review on the management of medication overuse headache: the step road from experience to evidence J Headache Pain 10 407 417 19802522 10.1007/s10194-009-0159-6
7. M Pompili G Serafini D Di Cosimo G Dominici M Innamorati D Lester A Forte N Girardi S De Filippis R Tatarelli P Martelletti 2010 Psychiatric comorbidity and suicide risk in patients with chronic migraine Neuropsychiatr Dis Treat 7 81 91 10.2147/NDT.S8467
8. Ferrari A, Tiraferri I, Neri L, Sternieri E (2010) Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. J Headache Pain. doi: 10.1007/s10194-010-0258-4
9. G Gentile S Missori M Borro A Sebastianelli M Simmaco P Martelletti 2010 Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine J Headache Pain 11 151 156 20213484 10.1007/s10194-010-0202-7 1:CAS:528:DC%2BC3cXjtlalsrg%3D
10. G Gentile M Borro N Lala S Missori M Simmaco P Martelletti 2010 Genetic polimorphysms related to efficacy and overuse of triptans in chronic migraine J Headache Pain 11 431 435 20652353 10.1007/s10194-010-0241-0 1:CAS:528: DC%2BC3cXhtFOqsr7K
11. G Gentile M Borro M Simmaco S Missori N Lala P Martelletti 2011 Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy Expert Opin Drug Metab Toxicol 7 39 47 21142809 10.1517/17425255.2011.538680 1:CAS:528:DC%2BC3cXhsFKqurrF
12. LJ Stovner E Tronvik K Hagen 2009 New drugs for migraine J Headache Pain 10 395 406 19795182 10.1007/s10194-009-0156-9 1:CAS:528:DC%2BD1MXhsVGlsbvO
13. I Farinelli S De Filippis G Coloprisco S Missori P Martelletti 2009 Future drugs for migraine Intern Emerg Med 4 367 373 19551474 10.1007/s11739-009-0273-0
14. P Martelletti 2006 The road ahead for chronic headache patients J Headache Pain 7 317 319 17058036 10.1007/s10194-006-0341-z (Pubitemid 46206316)
15. ®) in chronic daily headache: a five-year long experience J Headache Pain 7 407 412 17149565 10.1007/s10194-006-0344-9 1:CAS:528:DC%2BD2sXkt1Sjsw%3D%3D (Pubitemid 46085245)
16. Farinelli I, Dionisi I, Martelletti P (2010) Rehabilitating chronic migraine complicated by medication overuse headaches: how we can prevent relapse? Intern Emerg Med. doi: 10.1007/s11739-010-0410-9
17. A Askenazy 2010 Botulinum toxin type A for chronic migraine Current Neurol Neurosci Rep 10 140 146 10.1007/s11910-010-0087-5
18. FG Freitag 2010 Importance of botulinum toxin for prevention of migraine Expert Rev Neurother 10 339 340 20187855 10.1586/ern.10.11 1:CAS:528: DC%2BC3cXis1alu7c%3D
19. Chen S-P, Fuh J-L, Wang S-J (2010) OnabotulinumtoxinA: preventive treatment for chronic migraine. Curr Pain Headache Rep. doi: 10.1007/s11916-010-0150-6
20. RK Cady 2010 Onabotulinumtoxin A (botulinum toxin type-A) in the prevention of migraine Expert Opin Biol Ther 10 289 298 20088719 10.1517/14712590903586221 1:CAS:528:DC%2BC3cXovVCqtA%3D%3D